Contact PI/Project LeaderGERSTENFELD, LOUIS CHARLES
Awardee OrganizationBOSTON CHILDREN'S HOSPITAL
Description
Abstract Text
The hypothesis of this work is that the extracellular matrix of bone both
facilitates mineral nucleation and serves as the suprastructure for mineral
deposition. The identification of bone specific matrix components,
determination of their quantitative expression, the temporal regulation of
their expression, and their assembly will provide a crucial understanding
of the mechanisms of mineralization. Phosphoproteins have been identified
as a possible matrix component that facilitates and controls mineralization
in bone. IN order to further examine phosphoproteins' role in
mineralization two specific phosphoproteins will be characterized at the
protein level and subsequently cDNAs and genomic clones will be identified
and analyzed. Their expression, levels of regulation and mechanisms of
regulation will be analyzed during both in vivo bone development and in
vitro development in a mineralizing osteoblast culture system. Two other
genes associated with bone development (alkaline phosphatase and
osteocalcin) and the general group of bone specific cDNAs, identified by
subtractive hybridization screening, will be isolated. These genes will be
similarly analyzed as the phosphoproteins. Their expression will also be
examined during both in vitro and in vivo development and mineralization.
These experiments will provide information on the role of phosphoproteins
during bone development and mineralization. The comparative analysis of
several different bone specific genes will provide a more complete view of
the processes of cellular differentiation, and help identify the
interaction of several bone specific proteins and the crucial molecular
events of their quantitative and temporal expression during bone
development and mineralization.
Eunice Kennedy Shriver National Institute of Child Health and Human Development
CFDA Code
DUNS Number
076593722
UEI
Z1L9F1MM1RY3
Project Start Date
01-January-1987
Project End Date
31-December-1994
Budget Start Date
01-January-1992
Budget End Date
31-December-1992
Project Funding Information for 1992
Total Funding
$158,186
Direct Costs
$93,360
Indirect Costs
$64,826
Year
Funding IC
FY Total Cost by IC
1992
Eunice Kennedy Shriver National Institute of Child Health and Human Development
$158,186
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01HD022400-06
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01HD022400-06
Patents
No Patents information available for 5R01HD022400-06
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01HD022400-06
Clinical Studies
No Clinical Studies information available for 5R01HD022400-06
News and More
Related News Releases
No news release information available for 5R01HD022400-06
History
No Historical information available for 5R01HD022400-06
Similar Projects
No Similar Projects information available for 5R01HD022400-06